Diagnostic Breast MR Imaging: Current Status and Future Directions

Magnetic Resonance Imaging Clinics of North America

Volumn 18, Issue 1, 2010, Pages 57-74

  Morris, Elizabeth A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast imaging; Breast intervention; Breast MRI

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ALGORITHM; BREAST CANCER; CANCER SCREENING; CANCER STAGING; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DRUG RESPONSE; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MASTECTOMY; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; RECURRENT CANCER; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 70649109998     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2009.09.005     Document Type: Review

References (64)

1. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57 (2007) 75-89
2. American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS) (2003), American College of Radiology, Reston (VA)
3. Harms S.E. Technical report of the international working group on breast MRI. J Magn Reson Imaging 10 6 (1999) 979
4. Lehman C.D., Deperi E.R., Peacock S., et al. Clinical experience with MRI-guided vacuum-assisted breast biopsy. AJR Am J Roentgenol 184 (2005) 1782-1787
5. Sodickson D.K., Griswold M.A., and Jakob P.M. SMASH imaging. Magn Reson Imaging Clin N Am 7 (1999) 237-254
6. Esserman L., Hylton N., Yassa L., et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 17 (1999) 110-119
7. Berg W.A., Gutierrez L., NessAiver M.S., et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233 (2004) 830-849
8. Van Goethem, Shelfout K., Dijckmans, et al. MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. Eur Radiol 14 5 (2004) 809-816
9. Liberman L. Breast MR imaging in assessing extent of disease. Magn Reson Imaging N Am 14 (2006) 339-349
10. Liberman L., Morris E.A., Kim C.M., et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 180 (2003) 333-341
11. Lee S.G., Orel S.G., Woo I.J., et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 226 (2003) 773-778
12. Lehman C.D., Gastonis C., Kuhl C.K., et al. ACRIN Trial 6667 Investigators Group. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356 (2007) 1295-1303
13. Orel S.G., Reynolds C., Schnall M.D., et al. Breast carcinoma: MR imaging before re-excisional biopsy. Radiology 205 2 (1997) 429-436
14. Hylton N. MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy. Magn Reson Imaging N Am 14 (2006) 383-389
15. Partridge S.C., Gibbs J.E., Lu Y., et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol 184 (2005) 1774-1781
16. Schott A.F., Roubidoux M.A., Helvie M.A., et al. Clinical and radiologic assessment to predict breast cancer pathologic complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat 92 (2005) 231-238
17. Yeh E., Slanetz P., Kopans D.B., et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184 (2005) 868-877
18. Preda L., Villa G., Rizzo S., et al. Magnetic resonance mammography in the evaluation of recurrence at the prior lumpectomy site after conservative surgery and radiotherapy. Breast Cancer Res 8 (2006) R53
19. Morris E.A., Schwartz L.H., Dershaw D.D., et al. MR imaging of the breast in patients with occult primary breast cancer. Radiology 205 (1997) 437-440
20. Orel S.G., Weinstein S.P., Schnall M.D., et al. Breast imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 212 (1999) 543-549
21. Kuhl C.K., Schmutzler R.K., Leutner C.C., et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 215 (2000) 267-279
22. Warner E., Plewes D.B., Shumak R.S., et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 19 (2001) 3524-3531
23. Morris E.A., Liberman L., Ballon D.J., et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 181 (2003) 619-626
24. Podo F., Sardanelli F., Canese R., et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res 21 (2002) 115-124
25. Kuhl C.K., Schrading S., Leutner C.C., et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23 (2005) 8469-8476
26. Leach M.O., Boggis C.R., Dixon A.K., et al., MARIBS study group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365 (2005) 1769-1778
27. Kriege M., Brekelmans C.T., Boetes C., et al., Magnetic Resonance Imaging Screening Study Group. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351 (2004) 427-437
28. Knopp M.V., Weiss E., Sinn H.P., et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 10 (1999) 260-266
29. Boetes C., Strijk S.P., Holland R., et al. False-negative MR imaging of malignant breast tumors. Eur Radiol 7 (1997) 1231-1234
30. Hwang E.S., Kinkel K., Esserman L.J., et al. Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion and multicentricity. Ann Surg Oncol 10 (2003) 381-388
31. Menell J.H., Morris E.A., Dershaw D.D., et al. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 11 (2005) 382-390
32. Stomper P.C., D'Souza D.J., DiNitto P.A., et al. Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. AJR Am J Roentgenol 167 (1996) 1261-1265
33. Kerlikowski K., Grady D., Barclay J., et al. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 276 (1996) 33-38
34. Kolb T.M., Lichy J., and Newhouse J.H. Occult cancer in women with dense breasts: detection with screening US-diagnostic yield and tumor characteristics. Radiology 207 (1998) 191-199
35. Bluemke D.A., Gatsonis C.A., Chen M.H., et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 292 (2004) 2735-2742
36. Achouten van der Velden A.P., Boetes C., Bult P., et al. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg 192 (2006) 172-178
37. Morris E.A., Schwartz L.H., Drotman M.B., et al. Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR imaging: preliminary experience. Radiology 214 (2000) 67-72
38. Bedrosian I., Mick R., Orel S.G., et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98 (2003) 468-473
39. Bilimoria K.Y., Cambic A., Hansen N.M., et al. Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers. Arch Surg 142 (2007) 441-445
40. Deurloo E.E., Klein Zeggelink W.F., Teertstra H.J., et al. Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complimentary value for subgroups of patients. Eur Radiol 16 (2006) 692-701
41. Schelfout K., Van Goethem M., Kersschot E., et al. Contrast-enhanced MR imaging of breast lesion and effect on treatment. Eur J Surg 30 (2004) 501-507
42. Schnall M. MR imaging evaluation of cancer extent: is there clinical relevance?. Magn Reson Imaging N Am 14 (2006) 379-381
43. Holland R., Veling S.H., Mravunac M., et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56 (1985) 979-990
44. Fischer U., Baum F., and Luftner-Nagel S. Preopertive MR imaging in patients with breast cancer: preoperative staging, effects on recurrence rates, and outcome analysis. Magn Reson Imaging N Am 14 (2006) 351-362
45. Morrow M. Magnetic resonance imaging in breast cancer: one step forward, two steps back?. JAMA 292 (2004) 2779-2780
46. Morrow M. Limiting breast surgery to the proper minimum. Breast 14 (2005) 523-526
47. Morrow M., and Freedman G. A clinical oncology perspective on the use of breast MR. Magn Reson Imaging N Am 14 (2006) 363-378
48. Freedman G., Fowble B., Hanlon A., et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 44 5 (1999) 1005-1015
49. Wallace A.M., Daniel B.L., Jeffrey S.S., et al. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization. J Am Surg Coll 200 (2005) 527-537
50. Quan M.L., Sclafani L., Heerdt A.S., et al. Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer. Ann Surg Oncol 10 (2003) 1048-1053
51. Kepple J., Layeeque R., Klimberg V.S., et al. Correlation of magnetic resonance imaging and pathological size of infiltrating lobular carcinoma of the breast. Am J Surg 190 (2005) 623-627
52. Meisamy S., Bolan P.J., Baker E.H., et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1) H MR spectroscopy-a pilot study at 4T. Radiology 233 (2004) 424-431
53. Frei K., Kinkel K., Bonel H.M., et al. MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging. AJR Am J Roentgenol 175 (2000) 1577-1584
54. Lehman C.D., Blume J.D., Weatherall P., et al., International Breast MRI Consortium Working Group. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 203 (2005) 1898-1905
55. Lee C.H., Smith R.C., Levine J.A., et al. Clinical usefulness of MR imaging of the breast in the evaluation of the problematic mammogram. AJR Am J Roentgenol 173 (1999) 1323-1329
56. Friedman P., Sanders L., Russo J., et al. Detection and localization of occult lesions using breast magnetic resonance imaging: initial experience in a community hospital. Acad Radiol 12 (2005) 728-738
57. Berg W.A. Supplemental screening sonography in dense breasts. Radiol Clin North Am 42 5 (2004) 845-851
58. LaTrenta L.R., Menell J.H., Morris E.A., et al. Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. Radiology 227 (2003) 856-861
59. Kuhl C.K., Bieling H.B., Gieseke J., et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical phase dependency. Radiology 203 (1997) 137-144
60. Liberman L., Mason G., Morris E.A., et al. Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. AJR Am J Roentgenol 186 (2006) 426-430
61. Mountford C., Lean C., Malycha P., et al. Proton spectroscopy provides accurate pathology on biopsy and in vivo. J Magn Reson Imaging 24 (2006) 459-477
62. Bolan P.J., Nelson M.T., Yee D., et al. Imaging in breast cancer: magnetic resonance spectroscopy. Breast Cancer Res 7 (2005) 149-152
63. Bartella L., Morris E.A., Dershaw D.D., et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology 239 (2006) 686-692
64. Jolesz F.A., Hynynen K., McDannold N., et al. MR imaging-controlled focused ultrasound ablation: a noninvasive image-guided surgery. Magn Reson Imaging Clin N Am 13 (2005) 545-560